Fucoidans, which occur naturally in seaweeds, have previously
been shown to have a range of possible clinical applications. In a
review study, Dr Helen Fitton and her team from the biotechnology
company, Marinova, discuss the breadth and depth of new fucoidan
research – from their potential use in cancer treatment, to their
possible effcts on microbiome. Finally, they cover new techniques
for the measurement, production and delivery of fucoidans, which
are supporting the transition from research to clinical application.
